(19)
(11) EP 3 302 621 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.10.2024 Bulletin 2024/44

(45) Mention of the grant of the patent:
18.09.2024 Bulletin 2024/38

(21) Application number: 16804015.2

(22) Date of filing: 25.05.2016
(51) International Patent Classification (IPC): 
G16H 20/17(2018.01)
A61M 5/14(2006.01)
G16H 50/70(2018.01)
A61M 5/142(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 5/14; A61M 5/142; A61M 5/1408; A61M 5/1452; A61M 5/16827; A61M 2005/14208; A61M 2205/3576; A61M 2205/502; A61M 2205/52; G16H 40/67; G16H 70/20; A61M 5/172; G16H 20/17; G16H 40/63; G16H 70/40; G16H 40/40
(86) International application number:
PCT/US2016/034007
(87) International publication number:
WO 2016/196098 (08.12.2016 Gazette 2016/49)

(54)

PROCEDURE-BASED PROGRAMMING FOR INFUSION PUMPS

VERFAHRENSBASIERTE PROGRAMMIERUNG FÜR INFUSIONSPUMPEN

PROGRAMMATION BASÉE SUR UNE PROCÉDURE POUR POMPES À PERFUSION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 04.06.2015 US 201562170891 P

(43) Date of publication of application:
11.04.2018 Bulletin 2018/15

(60) Divisional application:
24193567.5 / 4434556

(73) Proprietor: ICU Medical, Inc.
San Clemente, CA 92673 (US)

(72) Inventor:
  • DROST, James, B.
    Plymouth, Minnesota 55442 (US)

(74) Representative: Harris, Oliver John Richard 
Novagraaf UK Centrum Norwich Research Park Colney Lane
Norwich NR4 7UG
Norwich NR4 7UG (GB)


(56) References cited: : 
EP-A1- 2 869 474
WO-A2-2007/127880
US-A1- 2007 219 495
US-A1- 2012 323 170
US-A1- 2015 041 419
WO-A2-02/11049
US-A1- 2002 038 392
US-A1- 2012 157 920
US-A1- 2012 323 212
US-B2- 8 894 631
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).